Fighting Cancer with
A Single Draw of Blood
Dedicated to advancing precision cancer
care for the benefit of patients everywhere.
Every cancer is different.
So is our approach.
No two people are the same, and neither are cancer tumors. The first step to smarter fighting cancer begins with uncovering the mutations that drive each person’s cancer. Precision medicine utilizes genomic information to tailor diagnoses and treatments to each patient’s cancer.
LiquidHALLMARK® detects cancer-driving gene mutations and viruses in each patient’s tumor from a single blood draw, allowing physicians to make more informed decision for their patients’ care.
Genomic Medicine: The future of cancer fighting
AmpliMARK™ - Our proprietary, ultrasensitive platform that advanced sequencing technology for cancer diagnostics
To transform cancer care, we continually research and invent new technologies and solutions